Network pharmacology and experimental validation to explore the effects and mechanisms of flavonoids luteolin and chrysoeriol against non‑small cell lung cancer

Key Points

• Luteolin and chrysoeriol show significant effects on inhibiting non-small cell lung cancer growth, enhancing treatment options.
• In vitro studies reveal that flavonoids cause a decrease in tumor cell proliferation by modulating specific pathways.
• Network pharmacology analysis highlights potential mechanisms of action, guiding future experiments and treatments.
• Findings suggest that flavonoids could offer new avenues for therapeutic intervention, needing further exploration.